×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Pfizer Acquires ResApp Health
Sleep Review
Global biopharmaceutical company Pfizer acquired University of Queensland startup ResApp Health Ltd for $179 million on Sept 26, 2022.
17 months ago
Pfizer Australia proposes acquisition of ResApp Health
Medical Device Network
Pfizer Australia has signed a binding scheme implementation deed for the acquisition of digital health company ResApp Health's 100% shares.
25 months ago
Pharma giant Pfizer wins over telehealth startup ResApp Health with $179 million takeover
Startup Daily
The battle for ASX-listed ResApp Health Ltd is over with pharmaceutical giant Pfizer acquiring the telehealth startup for $179 million.
19 months ago
UQ startup acquired by Pfizer - UQ News
The University of Queensland
Global biopharmaceutical company Pfizer has acquired University of Queensland startup ResApp Health Limited for $179 million.
19 months ago
ResApp Health, managing respiratory disease and sleep apnoea
The Citizen
ResApp Health Limited has launched a new product innovation. What is this product all about?
2 weeks ago
Resapp reports positive results for cough-based COVID-19 screening test for smartphones
BioWorld MedTech
Resapp Health Ltd. saw its stock shoot up 35% on the heels of positive clinical results for its new smartphone-based COVID-19 screening test...
25 months ago
Pfizer acquires Australian startup ResApp Health for $179 M
BioSpectrum Asia
One of the most exciting Australian biotech deals to come out of university research. image credit- ResApp Health.
19 months ago
Here's How Pfizer Is Boldly Moving into Digital Health
Medical Device and Diagnostic industry
Pharmaceutical companies are diving deeper into digital health. Earlier this week, Pfizer said it would acquire Resapp Health Ltd,...
25 months ago
ResApp Awarded CE Mark for Smartphone-based Diagnostic Test for Adult Respiratory Disease -
HIT Consultant
ResApp Health Ltd. announced it has received CE Mark approval for smartphone-based diagnostic test for adult respiratory disease.
55 months ago
ResApp acquired by Pfizer for $179 million
SmartCompany
ASX-listed ResApp developed a smartphone application that studies showed could identify a COVID-19 infection from a person's cough.
19 months ago